Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Pancreatic Neoplasms 10Cholangiocarcinoma 8Neoplasms 3Biliary Tract Neoplasms 3Bile Duct Neoplasms 3Jaundice 2Gallbladder Neoplasms 2Klatskin Tumor 1Gastrointestinal Neoplasms 1Fistula 1Disease 1Cholestasis 1Choledocholithiasis 1Cholangitis, Sclerosing 1Biliary Tract Diseases 1Biliary Fistula 1Bile Duct Diseases 1

Interventions

Oxaliplatin 18Surveys and Questionnaires 15Fluorouracil 15Capecitabine 13Leucovorin 12Blood Specimen Collection 11Irinotecan 10Standard of Care 7Cisplatin 7Endoscopic Mucosal Resection 6atezolizumab 5Specimen Handling 5Radiotherapy 5Educational Status 5Drug Therapy 5Docetaxel 5S 1 (combination) 4Radiosurgery 4Nivolumab 4Magnetic Resonance Spectroscopy 4Interviews as Topic 4Gemcitabine 4Everolimus 4Colonoscopy 4Biopsy 4Bevacizumab 4tegafur-gimeracil-oteracil 3pemigatinib 3apatinib 3Remote Patient Monitoring 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Gastrointestinal Neoplasms × Cholangiopancreatography, Endoscopic Retrograde × Clear all
NCT05994521 2024-10-01

INTERCEPT

McGill University Health Centre/Research Institute of the McGill University Health Centre

Phase NA Recruiting
110 enrolled
Gastrointestinal

Gastrointestinal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡